This report is being filed due to a patient death, unknown if device related.(b)(4) - expand g4 phase 1 and phase 2 study.Patient id: (b)(6).It was reported that on (b)(6) 2021, the patient presented with chronic, ischemic functional mitral regurgitation with leaflet tethering.One mitraclip was implanted, reducing the mr to grade 1+.There was no device deficiency.On (b)(6) 2022, the patient expired at home.The cause of death was not known.No additional information was provided regarding this issue.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the available information the cause of death cannot be determined.Additionally, death is listed in the mitraclip system instructions for use as a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|